Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 February 2020 | Story Valentino Ndaba
Charné Ferreira
Kovsies is proud of Charné Ferreira one of just 12 candidates to be placed on the Honours Roll of the South African Institute of Chartered Accountants.

The South African Institute of Chartered Accountants (SAICA) recently announced the candidates who wrote and successfully met the requirements of the Assessment of Professional Competence (APC) examination. One of 2 024 names released was that of Charné Ferreira, a University of the Free State (UFS) alumna.

Ferreira was among 3 560 candidates who attempted the APC in November 2019. This gruelling part of her journey to becoming a Chartered Accountant (CA) was a culmination of many years of intensive education and training.

Now a Senior Associate at PricewaterhouseCoopers, Ferreira reflects on how her career started with the decision to take Accounting as a subject in high school. In her second- and third-year as a Kovsie student, Ferreira challenged herself to become a tutor. This gave her the opportunity to secure a position as an Academic Trainee at the UFS School of Accountancy.

Recognising outstanding performance
Not only did Ferreira pass the most demanding Chartered Accounting test in South Africa, but she excelled and earned a place on the institute’s prestigious APC Honours Roll. SAICA honours only 12 exceptional candidates for their aptitude and skill. 

Excellence to match market demands
According to Freeman Nomvalo, CEO of SAICA: “In many ways this is the toughest exam because it requires aspirant Chartered Accountants (CASA) to apply their technical academic knowledge from multiple disciplines to a single but complex real-life business case study. To pass, candidates must demonstrate high levels of the skills employers have told us they want in the next generation of CAs (SA).

“Succeeding at this final test of professional competence requires advanced levels of critical thinking, the ability to work with technology, and the capacity to assimilate new information under pressure over a five-day period which culminates in an eight-hour assessment. It’s gruelling but it’s exactly the kind of challenge successful candidates will soon face as qualified CAs (SA),” added Nomvalo.

A word to the wise
Looking back at the building blocks that led her to this point, Ferreira shared invaluable advice for future candidates. “Ask for help, speak up if you do not know, speak up if you are drowning in stress. Your career is not a sprint, it is okay if you fail, as long as you get up again and the most important thing is, make time to rest, do not be so hard on yourself,” she said.

In congratulating Ferreira and the other UFS alumni who passed the 2019 Assessment of Professional Competence, Prof Frans Prinsloo, Director: School of Accountancy, also paid tribute to the excellent work of the UFS academics in the School who play a vital role in developing the knowledge, skills and values of the next generation of accounting professionals. “These results attest to the quality of the Chartered Accountancy education offered by the UFS,” he said.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept